Phreesia (NYSE:PHR) CFO Sells $136,233.09 in Stock

by · The Cerbat Gem

Phreesia, Inc. (NYSE:PHR – Get Free Report) CFO Balaji Gandhi sold 8,009 shares of the company’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $136,233.09. Following the transaction, the chief financial officer owned 156,231 shares in the company, valued at approximately $2,657,489.31. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Balaji Gandhi also recently made the following trade(s):

  • On Friday, October 17th, Balaji Gandhi sold 885 shares of Phreesia stock. The stock was sold at an average price of $22.36, for a total transaction of $19,788.60.

Phreesia Stock Performance

NYSE:PHR traded down $0.10 during trading hours on Monday, hitting $17.14. 760,277 shares of the company were exchanged, compared to its average volume of 1,018,096. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. Phreesia, Inc. has a 52-week low of $15.41 and a 52-week high of $32.76. The stock has a market capitalization of $1.03 billion, a price-to-earnings ratio of -171.33 and a beta of 0.61. The company’s 50 day moving average price is $18.95 and its 200-day moving average price is $23.69.

Phreesia (NYSE:PHR – Get Free Report) last posted its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million during the quarter, compared to the consensus estimate of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.25) earnings per share. As a group, research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Large investors have recently made changes to their positions in the company. Federated Hermes Inc. acquired a new stake in Phreesia during the third quarter valued at $32,000. Asset Management One Co. Ltd. purchased a new position in shares of Phreesia in the 3rd quarter valued at about $45,000. State of Alaska Department of Revenue purchased a new position in shares of Phreesia in the 3rd quarter valued at about $83,000. Farther Finance Advisors LLC raised its holdings in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after purchasing an additional 3,000 shares during the period. Finally, Anchor Investment Management LLC purchased a new position in Phreesia during the third quarter worth approximately $118,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Barclays cut their price objective on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a report on Tuesday, December 16th. Robert W. Baird dropped their target price on Phreesia from $31.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Zacks Research downgraded shares of Phreesia from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 6th. Truist Financial set a $24.00 price objective on shares of Phreesia in a research note on Thursday. Finally, BMO Capital Markets started coverage on shares of Phreesia in a report on Thursday, November 13th. They issued an “outperform” rating and a $32.00 price objective on the stock. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $30.06.

Check Out Our Latest Stock Report on PHR

About Phreesia

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Recommended Stories